T. Rowe Price discloses 3.7% Corpay (CPAY) stake in Schedule 13G/A
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. reports beneficial ownership of 2,593,145 shares of Corpay Inc. common stock, representing 3.7% of the class as of 12/31/2025. It has sole voting power over 2,471,482 shares and sole dispositive power over 2,593,136 shares.
The firm states the shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Corpay. It also expressly denies being the beneficial owner of the securities beyond what is required for this disclosure.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake in Corpay (CPAY) does T. Rowe Price report?
T. Rowe Price Associates, Inc. reports beneficial ownership of 2,593,145 shares of Corpay common stock, representing 3.7% of the outstanding class as of December 31, 2025, according to this amended Schedule 13G filing.
Is T. Rowe Price’s Corpay (CPAY) position considered passive or active?
T. Rowe Price characterizes its Corpay holdings as ordinary course of business and states they were not acquired to change or influence control of the company, which aligns with a passive investment stance under Schedule 13G.
Why did T. Rowe Price file an Amendment No. 5 for Corpay (CPAY)?
Amendment No. 5 updates T. Rowe Price’s beneficial ownership information in Corpay common stock as of December 31, 2025, reflecting a reported 3.7% stake and confirming its ordinary-course, non-control investment purpose.